The center was jointly built by Chongqing NanFang Numerical Control Equipment Co., Ltd., together with Chongqing University of Technology, Chongqing Medical University and other units. It covers an area of 1,000 square meters and currently has 12 research teams, which include product design, production technology, and technical standards. Quality inspection, clinical application, demonstration of industrialization and other complete industrial engineering innovation system.
"After the establishment of the center, we will conduct research on equipment and reagents in the field of blood testing, including Hemorheology Analyzer, blood sedimentation apparatus, thromboelastograph, in vitro diagnostic test kits, and tumor gene detection kits." Chen Zhongmin, deputy director of the School of Pharmacy and Bioengineering at Chongqing University of Technology, said that these devices and reagents can be used to detect and analyze the relevant indicators of diseases such as hypertension, kidney disease, tumors, and cardiovascular and cerebrovascular diseases. The disease causes, diagnosis, and prevention Treatment, treatment and disease monitoring have important clinical significance. The relevant scientific research results are expected to be gradually transformed from next year.